Search clinical trials for: controlled-release levodopa / carbidopa
Total 296 results
-
Orion Corporation, Orion PharmaCompletedIdiopathic Parkinson's DiseaseUnited Kingdom, Denmark, Ireland, Finland, Germany, Sweden
-
Osmotica Pharmaceutical US LLCCompletedParkinson's DiseaseArgentina
-
GenmabCompletedHead and Neck CancerUnited Kingdom, Belgium, Slovakia, Hungary
-
AbbVieIQVIA, formerly QuintilesCompletedAdvanced Parkinson's DiseaseUnited Kingdom, Czechia, United States, Australia, Canada, Israel, New Zealand, Poland, Portugal, Russian Federation, Thailand
-
Novartis PharmaceuticalsCompletedParkinson's Disease With End of Dose Wearing OffUnited States, Puerto Rico
-
Tanta UniversityEman Ibrahim Elberri, Faculty of Pharmacy, Tanta University; Fedaa Abd El-monem... and other collaboratorsRecruiting
-
Emory UniversityNational Institute of Mental Health (NIMH)Completed
-
Snyder, Robert W., M.D., Ph.D., P.C.Completed
-
Institute for Neurodegenerative DisordersGE Healthcare; PfizerCompletedParkinson Disease | Parkinsonian SyndromeSpain, Austria, Germany, Italy
-
Intec Pharma Ltd.UnknownParkinson's DiseaseUnited States, Israel, Italy, Spain, United Kingdom, Bulgaria, Germany, Poland, Slovakia, Ukraine
-
University of MichiganNational Institute on Aging (NIA)CompletedParkinsonian Signs in Older PersonsUnited States
-
Centre Hospitalier Universitaire VaudoisEcole Polytechnique Fédérale de LausanneCompletedDrug Effect | Spinal Cord InjuriesSwitzerland
-
AbbVie (prior sponsor, Abbott)Abbott Japan Co.,LtdCompleted
-
University of MichiganNational Institute of Neurological Disorders and Stroke (NINDS)Recruiting
-
Vanderbilt University Medical CenterUniversity of Pittsburgh; Emory University; Rutgers University; University of Pittsburgh...RecruitingDepressive Disorder, Treatment-Resistant | Cognitive Decline | Late Life Depression | Gait Impairment | LevodopaUnited States
-
University of WashingtonWithdrawnAlcohol Drinking
-
Laboratorios Andromaco S.A.Completed
-
NovartisCompleted
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)TerminatedDepression | Major Depressive Disorder | DysthymiaUnited States
-
Orion Corporation, Orion PharmaCompleted
-
AbbVie (prior sponsor, Abbott)Quintiles, Inc.CompletedParkinson's Disease | Dyskinesias | Severe Motor FluctuationsUnited States, Germany, New Zealand
-
AbbVieCompletedParkinson's Disease (PD)United States, Finland, Greece, Hungary, Italy, Slovakia, Spain
-
AbbVie (prior sponsor, Abbott)CompletedAdvanced Idiopathic Parkinson's Disease
-
Al-Azhar UniversityCompleted
-
The Affiliated Hospital of Qingdao UniversityNot yet recruiting
-
Neurocrine BiosciencesCompletedParkinson DiseaseUnited States
-
Acorda TherapeuticsCompleted
-
AbbVie (prior sponsor, Abbott)Quintiles, Inc.CompletedAdvanced Parkinson's DiseaseUnited States, Australia, Canada, Czech Republic, Finland, Germany, Israel, Italy, Netherlands, New Zealand, Poland, Portugal, Russian Federation, Spain, Thailand, United Kingdom
-
NovartisCompleted
-
NovartisCompleted
-
The Affiliated Hospital of Qingdao UniversityNot yet recruiting
-
NeuroDerm Ltd.CompletedParkinson's DiseaseUnited States, Israel, Italy, Austria
-
Washington University School of MedicineCompletedMotor Neuron Disease | Amyotrophic Lateral SclerosisUnited States
-
David EscobarThe Cleveland ClinicRecruiting
-
University of Wisconsin, MadisonTerminated
-
Orion Corporation, Orion PharmaCompleted
-
Shirley Ryan AbilityLabU.S. Department of EducationCompleted
-
Uppsala UniversitySwedish Society for Medical Research; Swedish Parkinson's Disease FoundationCompletedParkinson Disease | DyskinesiasSweden
-
University of RochesterRecruiting
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH); Columbia UniversitySuspendedDepressive DisorderUnited States
-
Huashan HospitalBoehringer IngelheimCompletedIdiopathic Parkinson's DiseaseChina
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed
-
Emory UniversityNational Institute of Mental Health (NIMH)Completed
-
Orion Corporation, Orion PharmaCompleted
-
XenoPort, Inc.CompletedA Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease SubjectsParkinson's DiseaseUnited States
-
SynAgile CorporationTFS Trial Form Support; Clintrex Research Corporation; Clinical Data Science...CompletedParkinson's DiseaseItaly, Luxembourg, Spain
-
Jaeb Center for Health ResearchNational Eye Institute (NEI)Completed
-
University Hospital of FerraraCompletedParkinson Disease | Effect of DrugItaly
-
Bial - Portela C S.A.Completed